Neuropeptides in hyperthermia.

Neuropeptides in hyperthermia. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Neuropeptides in hyperthermia. Abstract Text:

Fred Nyberg,Mathias Hallberg,Fred Nyberg,Mathias Hallberg,

Brain damage as a result of hyperthermia or heat-stress has been the focus of attention in many areas of neuroscience in recent years. Heat-induced alterations in structural components of the central nervous system (CNS) will obviously also influence the relevant transmitter systems, which may be involved in a variety of different behaviors. Indeed, many studies have indicated that excitatory amino acids, and monoaminergic and peptidergic systems are affected during hyperthermia. This chapter will address past and current research on various neuropeptides that have been implicated in the consequences of hyperthermia and various other heat disorders. However, considering the large and even increasing number of identified neuroactive peptides, it is necessary to limit this chapter to a few peptides or peptide systems, which have received particular attention in relation to hyperthermia. Among these are the opioid peptides, the tachykinins, calcitonin gene-related peptide (CGRP), and peptides belonging to the angiotensin system. Most of these neuropeptides are not only affected by hyperthermia and abnormal alterations in the body temperature but also are involved in the endogenous mechanisms of regulating body temperature. This review does not endeavor to fully cover the field but it does aim to give the reader an idea of how various neuropeptides may be involved in the control of body heat and how peptidergic systems are affected during various thermal changes, including both immediate and long-term consequences.

Neuropeptides in hyperthermia. Publishing Authors By Initials

F Nyberg,M Hallberg,F Nyberg,M Hallberg,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Neuropeptides in hyperthermia. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Progress in brain research

VOLUME: 162

Page Numbers: 277-93

Journal Abbreviation: Prog. Brain Res.

ISSN: 0079-6123

DAY: 24

MONTH: 07

YEAR: 2007

Neuropeptides in hyperthermia. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 376441

Neuropeptides in hyperthermia. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Neuropeptides in hyperthermia. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Neuropeptides in hyperthermia.

AFFILIATION: Department of Pharmaceutical Biosciences, Division of Biological Research on Drug Dependence, Uppsala University, S-751 24 Uppsala, Sweden. Fred.Nyberg@farmbio.uu.se

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Prog Brain Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Neuropeptides in hyperthermia Related Publications

• A new highly asymmetric chelation-controlled heck arylation.
• A reduced repair efficiency can explain increasing melanoma rates.
• A reflux-preventing valve in jejunoileal bypass.
• A survey of possible surgical methods of treating obesity.
• Abscess of the cerebellar lobe of otogenic origin; combined otolaryngologic and neurosurgical treatment in six cases.
• Allowing for the Opposite: The Parents of Asthmatic Children Cooperate by Making Use of Each Other's Differences.
• Central pre- and postsynaptic monoamine receptors in antidepressant therapy.
• ELIMINATION OF INTRAVENOUS FAT FROM THE BLOOD STREAM OF THE DOG.
• Effect of size and position on chest lesion detection.
• Elimination of exogenous lipids from the blood stream. An experimental, methodological and clinical study.
• Functional ability and health complaints among older people with a combination of public and informal care vs. public care only.
• Hospital admissions among people 65+ related to multimorbidity, municipal and outpatient care.
• Impact of delirium on professionals.
• Increasing incidence of brain tumours in sparsely populated areas.
• Iron status of 38-year-old women in Gothenburg, Sweden.
• Life Satisfaction in 6 European Countries: The Relationship to Health, Self-Esteem, and Social and Financial Resources among People (Aged 65-89) with Reduced Functional Capacity.
• Lymphocyte markers in newborn infants.
• Myasthenia gravis. Immunological studies in a young child treated with thymectomy and immunosuppressive drugs.
• Neuropeptides in hyperthermia.
• Older women and men with urinary symptoms.
• Phosphorylation-independent interaction between 14-3-3 and exoenzyme S: from structure to pathogenesis.
• Presentation of amino acid changes. A review.
• Small peptides mimicking substance P (1-7) and encompassing a C-terminal amide functionality.
• Structural and Biophysical Characterization of Human myo-Inositol Oxygenase.
• Studies in lead poisoning. Oral therapy with penicillamine: relationship between lead in blood and other laboratory tests.
• The economic implications of users willingness to increase knowledge capital in health informatics.
• The importance of bioavailability of dietary iron in relation to the expected effect from iron fortification.
• The relative importance of various laboratory measurements in the diagnosis of iron deficiency.
• Wheat fiber, phytates and iron absorption.
• [PLAN FOR THE INCREASE OF MEDICAL SCHOOLS IN NORWAY, 1966-1980.]